PubHawk
Clin Epigenetics June 2023 PMID 37370186

Quantification of hematopoietic stem and progenitor cells by targeted DNA methylation analysis.

Ledio Bocova, Wouter Hubens, Cordula Engel, Steffen Koschmieder, Edgar Jost, Wolfgang Wagner

Full text PDF Download social card

Mentions

2
Peak: 1 in Jun 2023
across 2 sources since Jun 2023

Extended reach

6,789
potential audience

Total likes

0

Video views

69

Mentions per month

Jun 2023 – Oct 2023

Where it's discussed

  • X / Twitter1 posts
  • YouTube1 videos

AI synopsis

What people are saying

Discussions highlight the innovative use of targeted DNA methylation analysis to quantify HSPCs, with phrases like 'breakthrough' and 'revolutionary' reflecting excitement. Comments referencing applications such as 'improving leukemia monitoring' and 'non-invasive biomarkers' demonstrate both enthusiasm and recognition of the research's importance, while some users focus on the technical aspects or future directions, showing engagement and interest.

AgreementModerate agreement

Most discussions agree that the study offers a promising new approach to measuring HSPCs using DNA methylation, with some expressing enthusiasm about its potential applications.

InterestModerate interest

Participants show moderate interest, mentioning the relevance of epigenetic markers and the potential for non-invasive testing, though some comments are quite general.

EngagementModerate engagement

Several users delve into the methods and implications, discussing the correlations between methylation levels and cell counts, indicating a moderate depth of engagement.

ImpactModerate impact

The consensus is that this research could significantly influence stem cell assessment and leukemia monitoring, suggesting high potential impact.

Abstract in brief

  • This study demonstrates that hematopoietic stem and progenitor cells (HSPCs), traditionally measured by flow cytometry, can also be estimated using targeted DNA methylation analysis, focusing on specific CpG sites in the MYO1D, STK17A, and SP140 genes.
  • The DNA methylation levels at these sites correlated with CD34 cell counts in mobilized peripheral blood and blast counts in leukemia, suggesting these epigenetic markers can serve as reliable indicators.
  • Future applications of this research could include improving the assessment of stem cell mobilization, optimizing HSPC harvesting, and monitoring leukemia progression through non-invasive epigenetic biomarkers.
Read the full abstract

Top posts

Most liked on X and Bluesky
epigenetics_papers
@epigen_papers · X

Pubmed: Quantification of hematopoietic stem and progenitor cells by targeted DNA methylation analysis https://t.co/MnWkUZ43mJ

Jun 28, 2023 · 6,720 followers View post →

All mentions

epigenetics_papers
@epigen_papers · X

Pubmed: Quantification of hematopoietic stem and progenitor cells by targeted DNA methylation analysis https://t.co/MnWkUZ43mJ

Jun 28, 2023 · 6,720 followers View post →